Diffuse diabetic macular edema: Pathology and implications for surgery

Developments in Ophthalmology

Volumn 39, Issue , 2007, Pages 88-95

  Gandorfer, A ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; DIABETIC RETINOPATHY; HOSPITALIZATION; HUMAN; METHODOLOGY; PATHOLOGY; PROGNOSIS; RETINA; RETINA MACULA CYSTOID EDEMA; REVIEW; VITRECTOMY; VITREOUS BODY;

CELL PROLIFERATION; DIABETIC RETINOPATHY; HUMANS; MACULAR EDEMA, CYSTOID; PROGNOSIS; RETINA; SEVERITY OF ILLNESS INDEX; VITRECTOMY; VITREOUS BODY;

EID: 33947546215     PISSN: 02503751     EISSN: 16622790     Source Type: Book Series    
DOI: 10.1159/000098501     Document Type: Review

References (44)

1. Klein R, Klein B, Moss S, Cruickshanks KC: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. 15. The long-term incidence of macular edema. Ophthalmology 1995;102:7-16.
2. Javitt JC, Canner JK, Sommer A: Cost effectiveness of current approaches to the control of retinopathy in type I diabetes. Ophthalmology 1989;96:255-264.
3. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report No 19. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol 1995;113:1144-1155.
4. Lee CM, Olk RJ: Modified grid laser photocoagulation for diffuse diabetic macular edema: long-term visual results. Ophthalmology 1991;98:1594-1602.
5. Bresnick GH: Diabetic macular edema. A review. Ophthalmology 1986;93:989-997.
6. Schepens CL, Avila MP, Jalkh AE, Trempe CL: Role of the vitreous in cystoid macular edema. Surv Ophthalmol 1984;28(suppl):499-504.
7. Sebag J: Diabetic vitreopathy. Ophthalmology 1996;103:205-206.
8. Nasrallah FP, Jalkh AE, Van Coppenolle F, Kado M, Trempe CL, McMeel JW, Schepens CL: The role of the vitreous in diabetic macular edema. Ophthalmology 1988;95:1335-1339.
9. Hikichi T, Fujio N, Akiba J, Azuma Y, Takahashi M, Yoshida A: Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology 1997;104:473-478.
10. Kishi S, Shimizu K: Clinical manifestations of posterior precortical vitreous pocket in proliferative diabetic retinopathy. Ophthalmology 1993;100:225-229.
11. Schwartz SD, Alexander R, Hiscott P, Gregor ZJ: Recognition of vitreoschisis in proliferative diabetic retinopathy. A useful landmark in vitrectomy for diabetic traction retinal detachment. Ophthalmology 1996;103:323-328.
12. Faulborn J, Bowald S: Microproliferations in proliferative diabetic retinopathy and their relationship to the vitreous: corresponding light and electron microscopic studies. Graefes Arch Clin Exp Ophthalmol 1985;223:130-138.
13. Sebag J: The Vitreous. Structure, Function, Pathobiology. New York, Springer, 1989.
14. Gandorfer A, Rohleder M, Grosselfinger S, Haritoglou C, Ulbig M, Kampik A: Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction. Am J Ophthalmol 2005;139:638-652.
15. Lewis H: The role of vitrectomy in the treatment of diabetic macular edema. Am J Ophthalmol 2001;131:123-125.
16. Jumper JM, Embabi SN, Toth CA, McCuen BW 2nd, Hatchell DL: Electron immunocytochemical analysis of posterior hyaloid associated with diabetic macular edema. Retina 2000;20:63-68.
17. Yamamoto T, Akabane N, Takeuchi S: Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol 2001;132:369-377.
18. Chen YS, Hackett SF, Schoenfeld DL, Vinores MA, Vinores SA, Campochiaro PA: Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br J Ophthalmol 1997;81:919-926.
19. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW, Group PSRR: Vascular permeability in experimental diabetes associated with reduced endothelial occludin content. Diabetes 1998;47:1953-1959.
20. Gandorfer A, Rohleder M, Kampik A: Epiretinal pathology of vitreomacular traction syndrome. Br J Ophthalmol 2002;86:902-909.
21. Kampik A, Green WR, Michels RG, Nase PK: Ultrastructural features of progressive idiopathic epiretinal membrane removed by vitreous surgery. Am J Ophthalmol 1980;90:797-809.
22. Kampik A, Kenyon KR, Michels RG, Green WR, de la Cruz ZC: Epiretinal and vitreous membranes. Comparative study of 56 cases. Arch Ophthalmol 1981;99:1445-1454.
23. Appiah AP, Hirose T, Kado M: A review of 324 cases of idiopathic premacular gliosis. Am J Ophthalmol 1988;106:533-535.
24. Wise GN: Clinical features of idiopathic preretinal macular fibrosis. Schoenberg Lecture. Am J Ophthalmol 1975;79:349-357.
25. Lewis H, Abrams GW, Blumenkranz MS, Campo RV: Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992;99:753-759.
26. Gandorfer A, Messmer EM, Ulbig MW, Kampik A: Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 2000;20:126-133.
27. Harbour JW, Smiddy WE, Flynn HW Jr, Rubsamen PE: Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 1996;121:405-413.
28. Yang CM: Surgical treatment for severe diabetic macular edema with massive hard exudates. Retina 2000;20:121-125.
29. Kaiser PK, Riemann CD, Sears JE, Lewis H: Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. Am J Ophthalmol 2001;131:44-49.
30. Pendergast SD: Vitrectomy for diabetic macular edema associated with a taut premacular posterior hyaloid. Curr Opin Ophthalmol 1998;9:71-75.
31. Pendergast SD, Hassan TS, Williams GA, Cox MS, Margherio RR, Ferrone PJ, Garretson BR, Trese MT: Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol 2000;130:178-186.
32. van Effenterre G, Guyot-Argenton C, Guiberteau B, Hany I, Lacotte JL: Macular edema caused by contraction of the posterior hyaloid in diabetic retinopathy. Surgical treatment of a series of 22 cases. J Fr Ophtalmol 1993;16:602-610.
33. Ikeda T, Sato K, Katano T, Hayashi Y: Attached posterior hyaloid membrane and the pathogenesis of honeycombed cystoid macular edema in patients with diabetes. Am J Ophthalmol 1999;127:478-479.
34. Ikeda T, Sato K, Katano T, Hayashi Y: Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes. Br J Ophthalmol 1999;83:12-14.
35. Tachi N, Ogino N: Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 1996;122:258-260.
36. La Heij EC, Hendrikse F, Kessel AG, Derhaag PJ: Vitrectomy results in diabetic macular oedema without evident vitreomacular traction. Graefes Arch Clin Exp Ophthalmol 2001;239:264-270.
37. Stefansson E, Landers MB 3rd, Wolbarsht ML: Increased retinal oxygen supply following panretinal photocoagulation and vitrectomy and lensectomy. Trans Am Ophthalmol Soc 1981;79:307-334.
38. Stefansson E, Landers MB 3rd, Wolbarsht ML: Vitrectomy, lensectomy, and ocular oxygenation. Retina 1982;2:159-166.
39. Stefansson E: The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand 2001;79:435-440.
40. Russell SR, Hageman GS: Optic disc, foveal, and extrafoveal damage due to surgical separation of the vitreous. Arch Ophthalmol 2001;119:1653-1658.
41. Gandorfer A, Ulbig M, Kampik A: Plasmin-assisted vitrectomy eliminates cortical vitreous remnants. Eye 2002;16:95-97.
42. Gandorfer A, Rohleder M, Charteris DG, Sethi C, Kampik A, Luthert P: Staining and peeling of the internal limiting membrane in the cat eye. Curr Eye Res 2005;30:977-987.
43. Nakamura T, Murata T, Hisatomi T, Enaida H, Sassa Y, Ueno A, Sakamoto T, Ishibashi T: Ultrastructure of the vitreoretinal interface following the removal of the internal limiting membrane using indocyanine green. Curr Eye Res 2003;27:395-399.
44. Gandorfer A, Haritoglou C, Kampik A, Charteris D: Ultrastructure of the vitreoretinal interface following removal of the internal limiting membrane using indocyanine green. Curr Eye Res 2004;29:319-320.